The Aneurysm drugs in development market research report provides comprehensive information on the therapeutics under development for Aneurysm, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses key aspects of the companies and drugs in development for Aneurysm. Buy the report here.
Smarter leaders trust GlobalData
The report also covers the descriptive pharmacological action of the therapeutics and the latest news and press releases. Additionally, the report provides an overview of the key players involved in therapeutic development for Aneurysm and features dormant and discontinued products.
GlobalData tracks eight drugs in development for Aneurysm by eight companies/universities/institutes. The top development phase for Aneurysm is preclinical with six drugs in that stage. The Aneurysm pipeline has five drugs in development by companies and three by universities/ institutes. Some of the companies in the Aneurysm pipeline products market are: Grand Pharmaceutical Group, Spanish National Research Council and University of Kentucky.
The key targets in the Aneurysm pipeline products market include Tyrosine 3 Monooxygenase, and Prostaglandin E Synthase.
The key mechanisms of action in the Aneurysm pipeline product include Tyrosine 3 Monooxygenase Inhibitor with one drug in Preclinical. The Aneurysm pipeline products include 0 routes of administration with the top ROA being
Aneurysm overview
An aneurysm is a weak or expanded bulge in the wall of an artery. The different types are abdominal aortic aneurysm (AAA), cerebral aneurysms, thoracic aortic aneurysm, and carotid, popliteal, mesenteric, and splenic aneurisms. Atherosclerosis, family history of aneurysm, high blood pressure, and injury to the aorta can be the causative parameters. Symptoms include lightheadedness; tachycardia; sudden, severe pain in the head, chest or back; and sudden loss of consciousness following a severe headache. CT scan, CT or MRI angiography, and ultrasound are used for diagnosis. Endovascular aneurysm repair (EVAR), open surgery, endovascular coiling, microvascular clipping, and catheter embolization are used as treatment options.
For a complete picture of Aneurysm’s pipeline drug market, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s pipeline drugs offers detailed profiles of pharmaceutical drugs in all stages of pre-clinical and clinical development, from discovery through to pre-registration. Coverage is limited to novel human medicinal drugs and biosimilars seeking market approval proprietary and is one of two primary repositories of pharmaceutical drug information offered by GlobalData through its Pharmaceutical Intelligence Center.
